Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.


Recent & Breaking News (NYSEAM:ZOM)

Zomedica Announces Shareholder Meeting Voting Results

GlobeNewswire September 25, 2020

Zomedica Announces Letter to Shareholders in Connection With Annual and Special Virtual-Only Meeting

GlobeNewswire September 14, 2020

Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference

GlobeNewswire September 10, 2020

Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA(TM)

GlobeNewswire September 8, 2020

Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting

GlobeNewswire August 27, 2020

Zomedica Announces Second Quarter 2020 Financial Results

GlobeNewswire August 10, 2020

Zomedica Adds Two New Directors To Board Annual Meeting Materials Availability

GlobeNewswire August 7, 2020

Zomedica Announces Management Change

GlobeNewswire August 3, 2020

Successful Remote Installation of TRUFORMA(TM)

GlobeNewswire July 21, 2020

Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering

GlobeNewswire July 7, 2020

Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering

GlobeNewswire July 1, 2020

Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering

GlobeNewswire July 1, 2020

PCG Research Announces Publication of Update Report Covering Zomedica Pharmaceuticals Corp.

Newsfile June 25, 2020

Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch

GlobeNewswire June 16, 2020

Zomedica Pharmaceuticals Corp. Closes $20 Million Public Offering

GlobeNewswire May 29, 2020

Zomedica Pharmaceuticals Corp. Announces $20 Million Public Offering

GlobeNewswire May 26, 2020

Zomedica Completes Verification of Three More Assays for its TRUFORMA(TM) Point-of-Care Diagnostic Platform

GlobeNewswire May 20, 2020

Zomedica Announces First Quarter 2020 Financial Results

GlobeNewswire May 11, 2020

Zomedica Completes Verification of its TRUFORMA(TM) Point-of-Care Diagnostic Platform and the First Assay, Canine total T4

GlobeNewswire April 21, 2020

Zomedica Provides Corporate Update

GlobeNewswire April 13, 2020